How to Perform a Broth Microdilution MIC Test: Protocol and Endpoint Reading

The broth microdilution minimum inhibitory concentration (MIC) test is a quantitative, reference-standard method for determining the lowest concentration of an antimicrobial agent that inhibits visible growth of a microorganism under defined conditions. This method is performed in a 96-well microtiter plate, where serial two-fold dilutions of an antimicrobial are inoculated with a standardized bacterial or yeast suspension, incubated, and then read to identify the MIC endpoint. The broth microdilution method is the gold standard for antimicrobial susceptibility testing in clinical and research laboratories, providing precise MIC values essential for resistance surveillance, drug development, and comparative efficacy studies. It is particularly useful when quantitative MIC data are required, such as for determining epidemiological cut-off values (ECVs), evaluating new antimicrobial compounds, or confirming resistance mechanisms identified by screening methods.

At a Glance

Scientific Principle

The broth microdilution MIC test is based on the principle of exposing a standardized microbial inoculum to a series of geometrically increasing concentrations of an antimicrobial agent in a liquid growth medium. The antimicrobial agent diffuses uniformly throughout the broth, ensuring consistent exposure of all microbial cells. After incubation, the MIC is defined as the lowest concentration of the antimicrobial that completely inhibits visible growth of the organism, as detected by the naked eye or by spectrophotometric measurement.

The method relies on the logarithmic relationship between antimicrobial concentration and microbial growth inhibition. Serial two-fold dilutions (e.g., 128, 64, 32, 16, 8, 4, 2, 1, 0.5, 0.25 µg/mL) provide a logarithmic scale that allows precise determination of the MIC within one two-fold dilution. The precision of the MIC value is inherently limited to the dilution factor, meaning that the true MIC lies between the reported value and the next lower concentration.

The choice of growth medium is critical. For most bacteria, cation-adjusted Mueller-Hinton broth (CAMHB) is the standard medium recommended by CLSI and EUCAST. For yeasts, RPMI 1640 medium with MOPS buffer (pH 7.0) is standard. The medium must support adequate growth of the test organism without antagonizing or enhancing the activity of the antimicrobial agent. For essential oils and other hydrophobic compounds, the addition of a dispersing agent such as Tween 80 (0.5–1% v/v) is necessary to ensure uniform distribution in the aqueous medium [3].

Materials and Instrumentation

Essential Materials

• 96-well microtiter plates: Sterile, flat-bottom, polystyrene plates are standard. For miniaturized assays, 384-well plates can be used with reduced volumes (30–50 µL) [4].
• Antimicrobial stock solutions: Prepared fresh or stored according to stability data. Stock solutions should be prepared at 10–20 times the highest desired test concentration to allow for dilution in the plate.
• Growth medium: Cation-adjusted Mueller-Hinton broth (CAMHB) for bacteria; RPMI 1640 with MOPS buffer for yeasts.
• Inoculum: Fresh overnight culture (16–18 hours) on non-selective agar.
• Sterile saline or phosphate-buffered saline: For inoculum standardization.
• McFarland turbidity standard: 0.5 McFarland standard (approximately 1.5 × 10⁸ CFU/mL for bacteria).
• Multichannel pipette: 8- or 12-channel pipette capable of dispensing 50–200 µL.
• Sterile reagent reservoirs: For medium and inoculum.
• Incubator: Set to 35 ± 2°C, with or without 5% CO₂ depending on organism requirements.
• Spectrophotometer or plate reader: Optional for automated endpoint reading.

Instrumentation Choices

The choice between standard 96-well plates and miniaturized 384-well plates depends on the available resources and the number of antimicrobials to be tested. Standard 96-well plates with 100–200 µL final volume are the most widely used and are compatible with all CLSI and EUCAST protocols. Miniaturized assays using 384-well plates with 30–50 µL final volume have been shown to produce MIC values within acceptable variability ranges for most antimicrobial-organism combinations, with the notable exception of micafungin against yeasts [4]. Miniaturization reduces reagent costs and antimicrobial consumption, which is particularly advantageous when testing expensive or scarce compounds.

For hydrophobic compounds such as essential oils, the addition of a dispersing agent (e.g., Tween 80 at 0.5–1% v/v) is essential to ensure uniform distribution in the aqueous medium [3]. The dispersing agent should be added to the growth medium before preparing the antimicrobial dilutions, and a control well containing the dispersing agent alone should be included to verify that it does not inhibit microbial growth.

Controls

Proper controls are essential for valid MIC determination. The following controls must be included in every assay:

Growth Control

A well containing growth medium and inoculum but no antimicrobial agent. This control confirms that the inoculum is viable and that the medium supports adequate growth. Visible turbidity should be present after incubation.

Sterility Control

A well containing growth medium only (no inoculum, no antimicrobial). This control confirms that the medium and plate are sterile. No turbidity should be present after incubation.

Quality Control Strains

Reference strains with known MIC ranges for the antimicrobial agents being tested must be included in each assay run. Common quality control strains include:

• Staphylococcus aureus ATCC 29213 (for Gram-positive bacteria)
• Escherichia coli ATCC 25922 (for Gram-negative bacteria)
• Pseudomonas aeruginosa ATCC 27853 (for non-fermenting Gram-negative bacteria)
• Candida parapsilosis ATCC 22019 or Candida krusei ATCC 6258 (for yeasts)

The MIC values obtained for quality control strains must fall within the established acceptable ranges for the test to be considered valid. If any quality control MIC falls outside the acceptable range, the entire assay must be repeated.

Solvent Control

If the antimicrobial agent is dissolved in a solvent other than water (e.g., DMSO, ethanol), a control well containing the same concentration of solvent without antimicrobial should be included. The final solvent concentration should not exceed 1% (v/v) to avoid solvent toxicity.

Dispersing Agent Control

When using dispersing agents such as Tween 80 for hydrophobic compounds, a control well containing the dispersing agent at the same concentration used in the test wells should be included [3].

Conceptual Workflow

Step 1: Prepare Antimicrobial Stock Solutions

Prepare antimicrobial stock solutions at 10–20 times the highest desired test concentration. For example, if the highest test concentration is 128 µg/mL, prepare a stock solution at 1280–2560 µg/mL. Use sterile distilled water, ethanol, or DMSO as appropriate for the antimicrobial. Record the solvent used and the final solvent concentration in the test wells.

Step 2: Prepare Serial Two-Fold Dilutions in the Plate

Add 100 µL of growth medium to all wells except the first column. Add 200 µL of the antimicrobial solution at twice the desired highest concentration to the first column wells. Using a multichannel pipette, transfer 100 µL from the first column to the second column, mix thoroughly by pipetting up and down 5–6 times, then transfer 100 µL from the second column to the third column. Continue this serial two-fold dilution across the plate, discarding 100 µL from the last column. This creates a two-fold dilution series where each well contains 100 µL of antimicrobial at twice the final desired concentration.

For example, to achieve final concentrations of 64, 32, 16, 8, 4, 2, 1, 0.5, 0.25, 0.125, 0.0625, and 0.03125 µg/mL, prepare the first column at 128 µg/mL (twice the highest final concentration) and perform serial two-fold dilutions.

Step 3: Prepare the Inoculum

From a fresh overnight culture (16–18 hours) on non-selective agar, suspend several morphologically similar colonies in sterile saline or phosphate-buffered saline. Adjust the turbidity to match a 0.5 McFarland standard (approximately 1.5 × 10⁸ CFU/mL for bacteria). This suspension should be used within 15–30 minutes of preparation.

For yeasts, the inoculum is prepared similarly but adjusted to a 0.5 McFarland standard (approximately 1–5 × 10⁶ CFU/mL), then diluted 1:100 in RPMI 1640 medium to achieve a final inoculum of 0.5–2.5 × 10³ CFU/mL.

Step 4: Dilute the Inoculum and Inoculate the Plate

Dilute the 0.5 McFarland suspension 1:100 in growth medium to achieve approximately 1.5 × 10⁶ CFU/mL. Add 100 µL of this diluted inoculum to each well containing antimicrobial, as well as to the growth control well. The final inoculum in each well should be approximately 5 × 10⁵ CFU/mL (for bacteria) or 0.5–2.5 × 10³ CFU/mL (for yeasts).

For miniaturized assays using 384-well plates, the volumes are reduced proportionally. For example, add 15 µL of antimicrobial at 4× the desired final concentration and 15 µL of inoculum at 2× the desired final concentration to achieve a 30 µL final volume [4].

Step 5: Incubate the Plate

Cover the plate with a sterile lid or adhesive seal. Incubate at 35 ± 2°C for 16–20 hours for bacteria, or 24–48 hours for yeasts. For fastidious organisms, incubation in 5% CO₂ may be required. To minimize evaporation, especially in miniaturized assays, incubate in a water-saturated atmosphere or use a humidified incubator [4].

Step 6: Read the MIC Endpoint

After incubation, examine each well for visible growth. The MIC is the lowest concentration of antimicrobial that completely inhibits visible growth. Growth is indicated by turbidity (cloudiness) or a pellet of cells at the bottom of the well. No growth is indicated by a clear well with no visible turbidity or pellet.

For yeasts, the MIC endpoint is defined as the lowest concentration that produces a prominent decrease in turbidity (approximately 50% inhibition compared to the growth control) for azoles and echinocandins, or complete inhibition (no visible growth) for amphotericin B and flucytosine [1].

Quality Checks

Pre-Assay Quality Checks

• Verify that the antimicrobial stock solution is within its expiration date and has been stored appropriately.
• Confirm that the growth medium is sterile and supports growth of the test organism.
• Check that the 0.5 McFarland standard is within its expiration date and has been properly mixed.
• Ensure that the incubator temperature is within the acceptable range (35 ± 2°C).

During-Assay Quality Checks

• Verify that the serial dilution was performed correctly by checking that the volume transferred is consistent.
• Confirm that the inoculum was added to all test wells and the growth control, but not to the sterility control.
• Check that the plate is properly sealed to prevent evaporation and contamination.

Post-Assay Quality Checks

• The growth control must show visible turbidity (adequate growth).
• The sterility control must show no turbidity (no contamination).
• Quality control strain MICs must fall within established acceptable ranges.
• The MIC for the test organism should be reproducible within one two-fold dilution when repeated.

Result Interpretation

Reading the MIC Endpoint

The MIC endpoint is read by examining each well for visible growth. For most bacteria, the endpoint is clear: the lowest concentration with no visible turbidity or pellet. For yeasts, the endpoint may be more subtle, particularly for azoles and echinocandins, where partial inhibition (trailing growth) can occur. In such cases, the MIC is read as the lowest concentration that produces a prominent decrease in turbidity (approximately 50% inhibition) compared to the growth control [1].

Recording Results

Record the MIC value in µg/mL. If the MIC falls between two concentrations (e.g., growth at 2 µg/mL but not at 4 µg/mL), record the higher concentration (4 µg/mL). If growth occurs at all concentrations tested, record the MIC as greater than the highest concentration tested (e.g., >128 µg/mL). If no growth occurs at any concentration, record the MIC as less than or equal to the lowest concentration tested (e.g., ≤0.03125 µg/mL).

Interpreting Results

Interpretation of MIC values requires established breakpoints or epidemiological cut-off values (ECVs). Breakpoints are clinical thresholds that categorize isolates as susceptible, intermediate, or resistant. ECVs are microbiological thresholds that distinguish wild-type isolates (those without acquired resistance mechanisms) from non-wild-type isolates. Both breakpoints and ECVs are organism- and antimicrobial-specific and are published by CLSI, EUCAST, and other organizations.

For research purposes, MIC values are often compared to those of reference strains or to historical data to assess changes in susceptibility over time. When testing novel compounds, the MIC is used as a primary measure of antimicrobial activity, with lower MIC values indicating greater potency.

Common Pitfalls in Endpoint Reading

• Trailing growth: Partial inhibition that makes it difficult to determine the endpoint. This is common with azoles against yeasts and with some bacteriostatic agents against bacteria. Use the 50% inhibition endpoint for azoles and echinocandins [1].
• Skipped wells: A well with no growth followed by growth at a higher concentration. This may indicate a dilution error or contamination. Repeat the assay if this occurs.
• Contamination: Growth in the sterility control or unexpected growth patterns. Discard the assay and repeat with fresh materials.
• Evaporation: Reduced volume in wells, particularly at the edges of the plate. This can concentrate the antimicrobial and lead to falsely low MIC values. Use a humidified incubator or seal the plate to minimize evaporation [4].

Troubleshooting

Limitations

The broth microdilution MIC test has several important limitations that must be considered when interpreting results:

• In vitro vs. in vivo correlation: MIC values are determined under standardized laboratory conditions that may not reflect the complex environment of an infection site. Factors such as pH, protein binding, biofilm formation, and host immune response can significantly affect antimicrobial activity in vivo.
• Two-fold dilution precision: The MIC is reported as one of the concentrations in the dilution series, meaning the true MIC could be up to one dilution lower than the reported value. This inherent imprecision must be considered when comparing MIC values.
• Medium-dependent activity: Some antimicrobials show different activity in different media. For example, the activity of aminoglycosides is reduced in acidic or anaerobic conditions, and the activity of daptomycin requires physiological calcium concentrations.
• Hydrophobic compounds: Essential oils and other hydrophobic compounds require dispersing agents for uniform distribution in aqueous media, which may affect antimicrobial activity [3]. The choice and concentration of dispersing agent must be carefully controlled.
• Trailing growth: Some organism-antimicrobial combinations produce partial inhibition that makes endpoint determination subjective. This is particularly problematic with azoles against yeasts, where trailing growth can lead to overestimation of MIC values [1].
• Miniaturization limitations: While miniaturized assays (30–50 µL in 384-well plates) generally produce comparable results to standard assays, some antimicrobial-organism combinations (e.g., micafungin against yeasts) show unacceptable variability [4].
• Not suitable for all organisms: Fastidious organisms, anaerobes, and slow-growing organisms may require modified protocols, different media, or extended incubation times.

Documentation

Proper documentation is essential for reproducibility and regulatory compliance. The following information should be recorded for each MIC assay:

Pre-Assay Documentation

• Date and time of assay setup
• Identity and source of test organism (strain number, ATCC number, clinical isolate identifier)
• Antimicrobial agent(s) tested (name, lot number, expiration date, stock concentration, solvent)
• Growth medium (type, lot number, expiration date)
• Plate type (96-well, 384-well, manufacturer, lot number)
• Incubator temperature and CO₂ concentration

During-Assay Documentation

• Inoculum preparation (culture age, McFarland reading, dilution factor)
• Serial dilution scheme (concentration range, dilution factor)
• Volume per well
• Incubation start time and duration

Post-Assay Documentation

• Incubation end time
• MIC values for test organism and QC strains
• Any deviations from standard protocol
• Interpretation of results (susceptible, intermediate, resistant, or wild-type/non-wild-type)
• Comments on any unusual observations (trailing growth, contamination, skipped wells)

Quality Control Documentation

• QC strain MIC values and acceptable ranges
• Pass/fail status for each QC strain
• Corrective actions taken if QC failed

Biosafety Considerations

The broth microdilution MIC test involves handling live microorganisms and should be performed in accordance with institutional biosafety guidelines and the CDC/NIH Biosafety in Microbiological and Biomedical Laboratories (BMBL) [6]. For routine testing of non-pathogenic laboratory strains (e.g., ATCC quality control strains), BSL-1 practices are appropriate. For clinical isolates or potentially pathogenic organisms, BSL-2 practices are required.

BSL-1 Practices (Non-Pathogenic Strains)

• Standard microbiological practices: no eating, drinking, or applying cosmetics in the laboratory
• Hand washing after handling microorganisms and before leaving the laboratory
• Decontamination of work surfaces daily and after spills
• Use of personal protective equipment (lab coat, gloves)
• Proper waste disposal (autoclave all contaminated materials)

BSL-2 Practices (Clinical Isolates or Potentially Pathogenic Organisms)

• All BSL-1 practices, plus:
• Restricted access to the laboratory
• Use of biological safety cabinet for all procedures that may generate aerosols
• Enhanced personal protective equipment (safety glasses or face shield if splash risk)
• Sharps precautions
• Specific training for handling pathogenic organisms

Additional Considerations

• Antimicrobial stock solutions may be hazardous; handle with appropriate precautions and dispose of according to institutional guidelines.
• For research involving recombinant or synthetic nucleic acid molecules (e.g., engineered strains), follow the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules [7].
• Essential oils and other volatile compounds may require additional ventilation or fume hood use [3].

Frequently Asked Questions

Q1: How do I choose the concentration range for my MIC test? The concentration range should bracket the expected MIC of the test organism. For known antimicrobials, use the range recommended by CLSI or EUCAST for the specific organism-antimicrobial combination. For novel compounds, a broad range (e.g., 0.03125–128 µg/mL) is recommended initially, then narrowed based on preliminary results. Include at least 7–10 two-fold dilutions to ensure adequate resolution.

Q2: What should I do if my QC strain MIC falls outside the acceptable range? If any QC strain MIC falls outside the established acceptable range, the entire assay is invalid and must be repeated. Common causes include antimicrobial degradation, dilution errors, incorrect inoculum size, or contaminated medium. Prepare fresh antimicrobial stock solutions, verify the inoculum standardization, and use fresh medium before repeating the assay.

Q3: Can I use the same protocol for both bacteria and yeasts? While the general workflow is similar, there are important differences. Bacteria are tested in CAMHB with a final inoculum of 5 × 10⁵ CFU/mL and incubated for 16–20 hours. Yeasts are tested in RPMI 1640 with MOPS buffer (pH 7.0) with a final inoculum of 0.5–2.5 × 10³ CFU/mL and incubated for 24–48 hours. The endpoint reading also differs: for yeasts, azoles and echinocandins are read at 50% inhibition, while amphotericin B and flucytosine are read at complete inhibition [1].

Q4: How do I handle hydrophobic compounds like essential oils in the broth microdilution assay? Hydrophobic compounds require a dispersing agent to ensure uniform distribution in the aqueous medium. Add Tween 80 at 0.5–1% (v/v) to the growth medium before preparing the antimicrobial dilutions [3]. Include a control well containing the dispersing agent at the same concentration without antimicrobial to verify that it does not inhibit microbial growth. Vortex or sonicate the antimicrobial-dispersing agent mixture to ensure complete dispersion before adding to the plate.

References and Further Reading

1. Siopi M, Leventaki S, Pachoulis I, et al. Evaluation of Sensititre YeastOne for antifungal susceptibility testing of Candida (Candidozyma) auris: misclassification of FKS1 mutants and overestimation of caspofungin resistance in a global collection of isolates. 2026. PubMed ID: 42132416. Link

2. Pérez L, da Silva CR, do Amaral Valente Sá LG, et al. Preventive Activity of an Arginine-Based Surfactant on the Formation of Mixed Biofilms of Fluconazole-Resistant Candida albicans and Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli on Central Venous Catheters. 2025. PubMed ID: 40149039. Link

3. Di Vito M, Mariotti M, Di Mercurio M, et al. Protocol for determining minimum inhibitory concentrations of essential oils against bacterial pathogens using broth microdilution. 2026. PubMed ID: 42166333. Link

4. Clarhaut J, Moreau J, Collet T, et al. Optimizing antimicrobial susceptibility testing: cost and environmental benefits of MIC volume reduction. 2025. PubMed ID: 41105522. Link

5. Dela Luna LAL, Yabes AM, Maramba-Lazarte CNC, et al. Antibacterial and Biofilm-inhibiting Activity of the Crude Psidium guajava Ethanolic Leaf Extracts against Biofilm-forming Staphylococcus epidermidis (ATCC 12228). 2025. PubMed ID: 41393916. Link

6. CDC and NIH. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition. U.S. Department of Health and Human Services, 2020. Link

7. National Institutes of Health. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. NIH Office of Science Policy. Link

8. National Center for Biotechnology Information. NCBI Bookshelf: Molecular Biology and Laboratory Methods. Link

Related Articles

• Minimum Inhibitory Concentration (MIC) Determination by Broth Microdilution: A Practical Protocol
• How to Perform an Etest for MIC Determination: Protocol and Interpretation
• How to Perform an Antibiotic Susceptibility Test Using the Etest Method
• How to Perform a KOH Test for Gram Reaction: Principle and Protocol
• Comparison of Disk Diffusion and Broth Microdilution for Antimicrobial Susceptibility Testing
• How to Perform a Kirby-Bauer Disk Diffusion Test: Protocol and Quality Control